Genetic Technologies Limited (GENE)
0.7650
0.00 (0.00%)
Inactive · Last trade price on Nov 14, 2024

Genetic Technologies Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Net Income
-12.02-11.75-7.13-7.08-6.29
Depreciation & Amortization
0.530.680.580.480.27
Loss (Gain) From Sale of Assets
-----0.04
Asset Writedown & Restructuring Costs
1.331.85---
Loss (Gain) From Sale of Investments
-----0.04
Stock-Based Compensation
0.120.130.440.71-0.01
Provision & Write-off of Bad Debts
-0.280.56--
Other Operating Activities
0.07-0.5-0.270.02-0.51
Change in Accounts Receivable
-0.260.26-1.89-0.280.03
Change in Inventory
0.120.07-0.350.01-0.06
Change in Accounts Payable
0.31-0.432.18-0.010.89
Change in Other Net Operating Assets
0.11-0.290.22-0.140.06
Operating Cash Flow
-9.68-9.72-5.66-6.3-5.71
Capital Expenditures
-0.03-0.02-0.06-0.75-0.04
Sale of Property, Plant & Equipment
----0.04
Cash Acquisitions
--0.49-3.4--
Sale (Purchase) of Intangibles
---0.03--
Investment in Securities
----0.04
Other Investing Activities
0.150.190.04-0.02
Investing Cash Flow
0.11-0.31-3.46-0.750.06
Short-Term Debt Issued
0.6----
Long-Term Debt Issued
----0.05
Total Debt Issued
0.6---0.05
Long-Term Debt Repaid
-0.35-0.34-0.27-0.24-0.18
Net Debt Issued (Repaid)
0.25-0.34-0.27-0.24-0.13
Issuance of Common Stock
2.587.17-15.921.79
Other Financing Activities
-0.01-0.92-0.01-1.97-3.3
Financing Cash Flow
2.825.92-0.2813.6918.36
Foreign Exchange Rate Adjustments
-0.090.230.230.04-0.63
Net Cash Flow
-6.83-3.88-9.176.6912.08
Free Cash Flow
-9.71-9.74-5.72-7.04-5.75
Free Cash Flow Margin
-100.41%-94.13%-62.09%-527.79%-686.29%
Free Cash Flow Per Share
-0.07-0.10-0.06-0.08-0.14
Cash Interest Paid
0.01--0.010.09
Cash Income Tax Paid
-1.75-1.96-2.4-1.33-1.04
Levered Free Cash Flow
-5.72-5.94-3.12-4.49-3.86
Unlevered Free Cash Flow
-5.69-5.92-3.11-4.48-3.82
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q